These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15584457)

  • 1. [A new approach for discovering minimal residual disease in patients with operable breast cancer].
    Iovchev I; Trifonov D; Nikolov S; Lazarov N; Dimitrov G
    Khirurgiia (Sofiia); 2003; 59(3):19-22. PubMed ID: 15584457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.
    Becker S; Becker-Pergola G; Wallwiener D; Solomayer EF; Fehm T
    Breast Cancer Res Treat; 2006 May; 97(1):91-6. PubMed ID: 16319975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
    Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
    Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
    Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
    Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and characterization of residual disease in breast cancer.
    Pantel K; Felber E; Schlimok G
    J Hematother; 1994; 3(4):315-22. PubMed ID: 7735827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of minimal bone marrow infiltration in patients with localized and metastatic Ewing sarcoma using RT-PCR.
    Sumerauer D; Vícha A; Kucerová H; Kodet R; Housková J; Bedrnícek J; Eckschlager T
    Folia Biol (Praha); 2001; 47(6):206-10. PubMed ID: 11768778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokeratin-19 in diagnosis of bone marrow metastases in patients with breast cancer - clinical results].
    Iovtchev I; Gŭlŭbova M; Vlaĭkova T; Vidolov P
    Khirurgiia (Sofiia); 2007; (3):43-5. PubMed ID: 18437110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
    Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
    Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors].
    Hinterberger W; Buxhofer V; Ogris E; Zelenka P; Kier P; Ruckser R; Dorner S; Habertheuer KH; Vedovelli H; Schindler S; Hinterberger-Fischer M
    Acta Med Austriaca Suppl; 2002; 59():2-8. PubMed ID: 12506753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Minimal metastatic and minimal residual disease in patients with Ewing tumors].
    Zoubek A; Pfleiderer C; Ambros PF; Kronberger M; Dworzak MN; Gruber B; Luegmayer A; Windhager R; Fink FM; Urban C
    Klin Padiatr; 1995; 207(4):242-7. PubMed ID: 7564161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
    Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
    Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A decade of sentinel lymph node biopsy for breast cancer: time for adaptations].
    Wobbes T
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):10-2. PubMed ID: 18240753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Micrometastatic disease and residual axillary disease. Breast cancer as an example Alct].
    Penault-Llorca F; Mishellany F
    Cancer Radiother; 2006 Nov; 10(6-7):338-42. PubMed ID: 16973394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual marrow disease: detection and significance of isolated tumour cells in bone marrow.
    Iorgulescu DG; Kiroff GK
    ANZ J Surg; 2001 Jun; 71(6):365-76. PubMed ID: 11409023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.